• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫平滑肌肿瘤组织学诊断中有丝分裂计数的可重复性。

Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus.

作者信息

Silverberg S G

出版信息

Hum Pathol. 1976 Jul;7(4):451-4. doi: 10.1016/s0046-8177(76)80058-5.

DOI:10.1016/s0046-8177(76)80058-5
PMID:939541
Abstract

In order to ascertain the reproducibility of the mitosis count in histologic tumor diagnosis, a reference set of 10 microscopic slides from smooth muscle tumors of the uterus was shown to six different pathologists, who were asked to record the number of mitotic figures per 10 high power fields in the most active region of each slide. The results, when tubulated, revealed considerable observer variation in this supposedly objective and quantitative diagnostic criterion. The diagnosis of benignity or malignancy, based on this criterion alone, were unamimous in only four of the 10 cases, whereas the diagnoses based on a constellation of histologic criteria were unanimous in all cases and correlated well with the subsequent clinical evolution of those cases with follow-up data. Possible reasons for the lack of reproducibility of the mitosis count are discussed. We conclude that a qualitative estimation of mitotic activity is helpful as one of the diagnostic and prognostic criteria in the assessment of uterine and other smooth muscle tumors, but that it cannot be used as the sole criterion for distinguishing benign from malignant tumors.

摘要

为了确定组织学肿瘤诊断中有丝分裂计数的可重复性,向六位不同的病理学家展示了一组来自子宫平滑肌瘤的10张显微切片,并要求他们记录每张切片最活跃区域每10个高倍视野中的有丝分裂象数量。将结果制成表格后发现,在这个本应客观且定量的诊断标准方面,观察者之间存在相当大的差异。仅基于这一标准做出的良性或恶性诊断,在10例病例中只有4例是一致的,而基于一系列组织学标准做出的诊断在所有病例中都是一致的,并且与那些有随访数据的病例随后的临床病程密切相关。文中讨论了有丝分裂计数缺乏可重复性的可能原因。我们得出结论,有丝分裂活性的定性评估作为评估子宫及其他平滑肌瘤的诊断和预后标准之一是有帮助的,但它不能用作区分良性肿瘤和恶性肿瘤的唯一标准。

相似文献

1
Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus.子宫平滑肌肿瘤组织学诊断中有丝分裂计数的可重复性。
Hum Pathol. 1976 Jul;7(4):451-4. doi: 10.1016/s0046-8177(76)80058-5.
2
Morphologic features of prognostic significance in uterine smooth muscle tumors: a review of eighty-four cases.
Am J Obstet Gynecol. 1979 Sep 1;135(1):109-14.
3
[Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].[子宫交界性平滑肌肿瘤的组织学诊断与临床特征]
Zhonghua Fu Chan Ke Za Zhi. 1994 Apr;29(4):201-4, 251.
4
[Quantitative morphological criteria of uterine myoma development].[子宫平滑肌瘤发生发展的定量形态学标准]
Akush Ginekol (Mosk). 1981 Apr(4):16-20.
5
[Smooth muscle neoplasms of the uterus--a 51 cases study].[子宫平滑肌肿瘤——51例病例研究]
Zhonghua Bing Li Xue Za Zhi. 1996 Oct;25(5):263-5.
6
[Mesenchymal uterine tumors. Leiomyomas].[间质性子宫肿瘤。平滑肌瘤]
Pathologe. 2009 Jul;30(4):274-83. doi: 10.1007/s00292-009-1160-1.
7
Uterine smooth muscle tumors: utility of classification by proliferation, ploidy, and prognostic markers versus traditional histopathology.
Arch Pathol Lab Med. 2000 Feb;124(2):221-7. doi: 10.5858/2000-124-0221-USMT.
8
Prognostically favorable "mitotically active" smooth-muscle tumors of the uterus. A clinicopathologic study of ten cases.
Am J Surg Pathol. 1988 Jan;12(1):1-8. doi: 10.1097/00000478-198801000-00001.
9
Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases.胃肠道和腹膜后平滑肌肿瘤:100例病理分析
Cancer. 1977 Jan;39(1):255-62. doi: 10.1002/1097-0142(197701)39:1<255::aid-cncr2820390139>3.0.co;2-h.
10
Smooth muscle tumors of the ovary: a clinicopathologic study of 54 cases emphasizing prognostic criteria, histologic variants, and differential diagnosis.卵巢平滑肌瘤:54例临床病理研究,重点关注预后标准、组织学变异及鉴别诊断
Am J Surg Pathol. 2004 Nov;28(11):1436-51. doi: 10.1097/01.pas.0000141393.99300.d0.

引用本文的文献

1
Pathways to clinical CLARITY: volumetric analysis of irregular, soft, and heterogeneous tissues in development and disease.通往临床 CLARITY 之路:发育和疾病中不规则、柔软和异质组织的容积分析。
Sci Rep. 2017 Jul 19;7(1):5899. doi: 10.1038/s41598-017-05614-4.
2
Diagnostic Implication and Clinical Relevance of Ancillary Techniques in Clinical Pathology Practice.辅助技术在临床病理学实践中的诊断意义及临床相关性
Clin Med Insights Pathol. 2016 Mar 23;9:5-11. doi: 10.4137/CPath.S32784. eCollection 2016.
3
Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas.
基于熵的自适应核纹理特征是子宫肉瘤总体人群中的独立预后标志物。
Cytometry A. 2015 Apr;87(4):315-25. doi: 10.1002/cyto.a.22601. Epub 2014 Dec 5.
4
Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.增殖指数(Ki-67)的观察者间一致性在肺类癌中优于有丝分裂计数。
Virchows Arch. 2013 May;462(5):507-13. doi: 10.1007/s00428-013-1408-2. Epub 2013 Apr 5.
5
A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.核分级系统是上皮样弥漫性恶性胸膜间皮瘤生存的有力预测指标。
Mod Pathol. 2012 Feb;25(2):260-71. doi: 10.1038/modpathol.2011.146. Epub 2011 Oct 7.
6
A new scoring system using multiple immunohistochemical markers for diagnosis of uterine smooth muscle tumors.一种使用多种免疫组织化学标志物诊断子宫平滑肌肿瘤的新评分系统。
J Cell Mol Med. 2006 Jan-Mar;10(1):197-205. doi: 10.1111/j.1582-4934.2006.tb00300.x.
7
Comparison of Ki-67 equivalent antibodies.Ki-67等效抗体的比较。
J Clin Pathol. 2002 Jun;55(6):467-71. doi: 10.1136/jcp.55.6.467.
8
Value of adequate fixation for accurate histological interpretation.充分固定对准确组织学解释的价值。
J Clin Pathol. 1993 Feb;46(2):191. doi: 10.1136/jcp.46.2.191.
9
Which proliferation markers for routine immunohistology? A comparison of five antibodies.常规免疫组织化学中使用哪些增殖标志物?五种抗体的比较。
J Clin Pathol. 1994 Nov;47(11):1010-4. doi: 10.1136/jcp.47.11.1010.
10
A rapid and simple staining method, using toluidine blue, for analysing mitotic figures in tissue sections.一种使用甲苯胺蓝的快速简便的染色方法,用于分析组织切片中的有丝分裂图像。
Histochem J. 1993 Aug;25(8):569-77.